MN
Manju Nandra
About Manju Nandra
Manju Nandra has 20 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Nandra Hospitals Private Limited and Amigo Hospitals Private Limited. Formerly with 3 companies, such as Av Meditech Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bergen Healthcare Private Limited
U85110CH1995PTC016736
|
Additional Director | 30 Sep 2011 | 1995 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Av Meditech Private Limited
U85110HR2006PTC126334
|
Director | 20 Jun 2006 | 2006 | Active |
Nandra Hospitals Private Limited
U85100HR2017PTC070964
|
Director | 29 Sep 2017 | 2017 | Strike Off |
Amigo Hospitals Private Limited
U85110CH2011PTC032797
|
Director | 09 Mar 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manju Nandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manju Nandra
Manju Nandra has 20 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Nandra Hospitals Private Limited and Amigo Hospitals Private Limited. Formerly with 3 companies, such as Av Meditech Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Manju Nandra is associated with 1 company as Director and Additional Director.
Manju Nandra has expertise in General Business, Healthcare and other sectors.
Manju Nandra has 20 years in corporate governance.